NCT00000642View on ClinicalTrials.gov

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Conditions
HIV InfectionsPregnancy
Interventions
DRUG

CD4-IgG

Trial Locations (2)

11203

SUNY - Brooklyn, Brooklyn

77030

Texas Children's Hosp / Baylor Univ, Houston

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH